Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S)

Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin

(2016) Emilie Bahne et al.   DIABETES OBESITY & METABOLISM

Current Concepts on the Pathogenesis of Type 1 Diabetes—Considerations for Attempts to Prevent and Reverse the Disease

(2015) Mark A. Atkinson et al.   DIABETES CARE

Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA)

(2015) R. Buzzetti et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota

(2015) Kristoffer Forslund et al.   NATURE

Combination immunotherapies for type 1 diabetes mellitus

(2015) Paolo Pozzilli et al.   Nature Reviews Endocrinology

Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement

(2015) Ernesto Maddaloni et al.   PLoS One

Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8+T Effector Memory Subset

(2015) Núria Alonso et al.   PLoS One

Dipeptidyl Peptidase 4 Inhibitor Sitagliptin Maintains β-Cell Function in Patients With Recent-Onset Latent Autoimmune Diabetes in Adults: One Year Prospective Study

(2014) Yunjuan Zhao et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial

(2014) Kurt J Griffin et al.   Lancet Diabetes & Endocrinology

C-Peptide Levels in Latent Autoimmune Diabetes in Adults Treated With Linagliptin Versus Glimepiride: Exploratory Results From a 2-Year Double-Blind, Randomized, Controlled Study: Table 1

(2013) Odd Erik Johansen et al.   DIABETES CARE

Slowly Progressive Type 1 Diabetes Treated with Metformin for Five Years after Onset

(2013) Takumi Hirata et al.   INTERNAL MEDICINE

Type 1 diabetes

(2013) Mark A Atkinson et al.   LANCET

Frequency, Immunogenetics, and Clinical Characteristics of Latent Autoimmune Diabetes in China (LADA China Study): A Nationwide, Multicenter, Clinic-Based Cross-Sectional Study

(2012) Z. Zhou et al.   DIABETES

Sitagliptin in Glutamic Acid Decarboxylase Antibody-Positive Diabetes Mellitus

(2012) Narayanan Kandasamy et al.   Endocrine Practice

Effect of Sitagliptin on Post-Prandial Glucagon and GLP-1 Levels in Patients With Type 1 Diabetes: Investigator-Initiated, Double-Blind, Randomized, Placebo-Controlled Trial

(2012) Satish Garg et al.   Endocrine Practice

Pioglitazone may accelerate disease course of slowly progressive type 1 diabetes

(2011) Akira Shimada et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial

(2011) S. L. Ellis et al.   DIABETIC MEDICINE

Heterogeneity of T1DM raises questions for therapy

(2011) Paolo Pozzilli   Nature Reviews Endocrinology

Sitagliptin (MK0431) Inhibition of Dipeptidyl Peptidase IV Decreases Nonobese Diabetic Mouse CD4+ T-Cell Migration Through Incretin-Dependent and -Independent Pathways

(2010) S.-J. Kim et al.   DIABETES

Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells

(2010) I. Hadjiyanni et al.   DIABETOLOGIA

Reversal of New-Onset Diabetes through Modulating Inflammation and Stimulating β-Cell Replication in Nonobese Diabetic Mice by a Dipeptidyl Peptidase IV Inhibitor

(2010) Lei Tian et al.   ENDOCRINOLOGY

Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor restores normoglycaemia in non-obese diabetic mice

(2009) W. L. Suarez-Pinzon et al.   DIABETOLOGIA

Insulin Intervention in Slowly Progressive Insulin-Dependent (Type 1) Diabetes Mellitus

(2008) Taro Maruyama et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM